Hohn David C 4
4 · CLEVELAND BIOLABS INC · Filed Apr 6, 2012
Insider Transaction Report
Form 4
Hohn David C
Director
Transactions
- Purchase
Common Stock, par value $0.005 per share
2012-04-04$1.71/sh+1,000$1,710→ 3,000 total
Footnotes (1)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2011.